APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Disease Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Disease Drugs Market Outlook and Growth Opportunities 2026

22 December 2025213 pages

Choose your research edition.

Industry ResearchPet Disease Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Disease Drugs Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Pet Disease Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Disease Drugs Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Disease Drugs Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Pet Disease Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Disease Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Disease Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Disease Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Disease Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Disease Drugs market include Zoetis, Merck & Co., Inc., Zuche Pharmaceuticals, Virbac, Vetoquinol S.A., VETINDIA Pharmaceuticals, SOUND Technologies, SeQuent Scientific and Richter Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Disease Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Disease Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Disease Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Disease Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Disease Drugs Segment by Company

Zoetis

Merck & Co., Inc.

Zuche Pharmaceuticals

Virbac

Vetoquinol S.A.

VETINDIA Pharmaceuticals

SOUND Technologies

SeQuent Scientific

Richter Pharma

Ourofino Animal Health

Norbrook Laboratories

Multi Radiance Medical

Morvel Laboratories

LABINDIA Healthcare

K-Laser USA

IRM Enterprises

Fidelis Animal Health

Elanco Animal Health

Dechra Pharmaceuticals

Chanelle Pharma

Ceva

Century Pharmaceuticals

Calier

Boehringer Ingelheim

Bimeda

Avazzia

Assisi Animal Health

Ashish Life Science

Pet Disease Drugs Segment by Type

Analgesics

Anti-inflammatory

Parasiticides

Anti-infectives

Others

Pet Disease Drugs Segment by Application

Behavioral Diseases

Pain

Dermatologic Diseases

Orthopedic Diseases

Infectious Diseases

Other

Pet Disease Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pet Disease Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pet Disease Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Disease Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Disease Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Disease Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Disease Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Disease Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Disease Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Disease Drugs industry.

Chapter 3: Detailed analysis of Pet Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pet Disease Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pet Disease Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Disease Drugs Industry Trends Table 2. Pet Disease Drugs Industry Drivers Table 3. Pet Disease Drugs Industry Opportunities and Challenges Table 4. Pet Disease Drugs Industry Restraints Table 5. Global Pet Disease Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Disease Drugs Revenue Share by Company (2021-2026) Table 7. Global Pet Disease Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pet Disease Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Pet Disease Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Pet Disease Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pet Disease Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Pet Disease Drugs Company, Product Type & Application Table 13. Global Pet Disease Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Analgesics Table 18. Significant Companies of Anti-inflammatory Table 19. Significant Companies of Parasiticides Table 20. Significant Companies of Anti-infectives Table 21. Significant Companies of Others Table 22. Global Pet Disease Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Pet Disease Drugs Sales Volume by Type (2021-2026) & (k units) Table 24. Global Pet Disease Drugs Sales Volume by Type (2027-2032) & (k units) Table 25. Global Pet Disease Drugs Sales Volume Share by Type (2021-2026) Table 26. Global Pet Disease Drugs Sales Volume Share by Type (2027-2032) Table 27. Global Pet Disease Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pet Disease Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Pet Disease Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Pet Disease Drugs Sales Value Share by Type (2021-2026) Table 31. Global Pet Disease Drugs Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Behavioral Diseases Table 33. Significant Companies of Pain Table 34. Significant Companies of Dermatologic Diseases Table 35. Significant Companies of Orthopedic Diseases Table 36. Significant Companies of Infectious Diseases Table 37. Significant Companies of Other Table 38. Global Pet Disease Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Pet Disease Drugs Sales Volume by Application (2021-2026) & (k units) Table 40. Global Pet Disease Drugs Sales Volume by Application (2027-2032) & (k units) Table 41. Global Pet Disease Drugs Sales Volume Share by Application (2021-2026) Table 42. Global Pet Disease Drugs Sales Volume Share by Application (2027-2032) Table 43. Global Pet Disease Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Pet Disease Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Pet Disease Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Pet Disease Drugs Sales Value Share by Application (2021-2026) Table 47. Global Pet Disease Drugs Sales Value Share by Application (2027-2032) Table 48. Global Pet Disease Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 49. Global Pet Disease Drugs Sales by Region (2021-2026) & (k units) Table 50. Global Pet Disease Drugs Sales Market Share by Region (2021-2026) Table 51. Global Pet Disease Drugs Sales by Region (2027-2032) & (k units) Table 52. Global Pet Disease Drugs Sales Market Share by Region (2027-2032) Table 53. Global Pet Disease Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Pet Disease Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Pet Disease Drugs Sales Value Share by Region (2021-2026) Table 56. Global Pet Disease Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Pet Disease Drugs Sales Value Share by Region (2027-2032) Table 58. Global Pet Disease Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 59. Global Pet Disease Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 60. Global Pet Disease Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 61. Global Pet Disease Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 63. Global Pet Disease Drugs Sales Market Share by Country (2021-2026) Table 64. Global Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 65. Global Pet Disease Drugs Sales Market Share by Country (2027-2032) Table 66. Global Pet Disease Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Pet Disease Drugs Sales Value Market Share by Country (2021-2026) Table 68. Global Pet Disease Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Pet Disease Drugs Sales Value Market Share by Country (2027-2032) Table 70. Zoetis Company Information Table 71. Zoetis Business Overview Table 72. Zoetis Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Zoetis Pet Disease Drugs Product Portfolio Table 74. Zoetis Recent Development Table 75. Merck & Co., Inc. Company Information Table 76. Merck & Co., Inc. Business Overview Table 77. Merck & Co., Inc. Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Merck & Co., Inc. Pet Disease Drugs Product Portfolio Table 79. Merck & Co., Inc. Recent Development Table 80. Zuche Pharmaceuticals Company Information Table 81. Zuche Pharmaceuticals Business Overview Table 82. Zuche Pharmaceuticals Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Zuche Pharmaceuticals Pet Disease Drugs Product Portfolio Table 84. Zuche Pharmaceuticals Recent Development Table 85. Virbac Company Information Table 86. Virbac Business Overview Table 87. Virbac Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Virbac Pet Disease Drugs Product Portfolio Table 89. Virbac Recent Development Table 90. Vetoquinol S.A. Company Information Table 91. Vetoquinol S.A. Business Overview Table 92. Vetoquinol S.A. Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Vetoquinol S.A. Pet Disease Drugs Product Portfolio Table 94. Vetoquinol S.A. Recent Development Table 95. VETINDIA Pharmaceuticals Company Information Table 96. VETINDIA Pharmaceuticals Business Overview Table 97. VETINDIA Pharmaceuticals Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolio Table 99. VETINDIA Pharmaceuticals Recent Development Table 100. SOUND Technologies Company Information Table 101. SOUND Technologies Business Overview Table 102. SOUND Technologies Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. SOUND Technologies Pet Disease Drugs Product Portfolio Table 104. SOUND Technologies Recent Development Table 105. SeQuent Scientific Company Information Table 106. SeQuent Scientific Business Overview Table 107. SeQuent Scientific Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. SeQuent Scientific Pet Disease Drugs Product Portfolio Table 109. SeQuent Scientific Recent Development Table 110. Richter Pharma Company Information Table 111. Richter Pharma Business Overview Table 112. Richter Pharma Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Richter Pharma Pet Disease Drugs Product Portfolio Table 114. Richter Pharma Recent Development Table 115. Ourofino Animal Health Company Information Table 116. Ourofino Animal Health Business Overview Table 117. Ourofino Animal Health Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Ourofino Animal Health Pet Disease Drugs Product Portfolio Table 119. Ourofino Animal Health Recent Development Table 120. Norbrook Laboratories Company Information Table 121. Norbrook Laboratories Business Overview Table 122. Norbrook Laboratories Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Norbrook Laboratories Pet Disease Drugs Product Portfolio Table 124. Norbrook Laboratories Recent Development Table 125. Multi Radiance Medical Company Information Table 126. Multi Radiance Medical Business Overview Table 127. Multi Radiance Medical Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Multi Radiance Medical Pet Disease Drugs Product Portfolio Table 129. Multi Radiance Medical Recent Development Table 130. Morvel Laboratories Company Information Table 131. Morvel Laboratories Business Overview Table 132. Morvel Laboratories Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Morvel Laboratories Pet Disease Drugs Product Portfolio Table 134. Morvel Laboratories Recent Development Table 135. LABINDIA Healthcare Company Information Table 136. LABINDIA Healthcare Business Overview Table 137. LABINDIA Healthcare Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. LABINDIA Healthcare Pet Disease Drugs Product Portfolio Table 139. LABINDIA Healthcare Recent Development Table 140. K-Laser USA Company Information Table 141. K-Laser USA Business Overview Table 142. K-Laser USA Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 143. K-Laser USA Pet Disease Drugs Product Portfolio Table 144. K-Laser USA Recent Development Table 145. IRM Enterprises Company Information Table 146. IRM Enterprises Business Overview Table 147. IRM Enterprises Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 148. IRM Enterprises Pet Disease Drugs Product Portfolio Table 149. IRM Enterprises Recent Development Table 150. Fidelis Animal Health Company Information Table 151. Fidelis Animal Health Business Overview Table 152. Fidelis Animal Health Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 153. Fidelis Animal Health Pet Disease Drugs Product Portfolio Table 154. Fidelis Animal Health Recent Development Table 155. Elanco Animal Health Company Information Table 156. Elanco Animal Health Business Overview Table 157. Elanco Animal Health Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 158. Elanco Animal Health Pet Disease Drugs Product Portfolio Table 159. Elanco Animal Health Recent Development Table 160. Dechra Pharmaceuticals Company Information Table 161. Dechra Pharmaceuticals Business Overview Table 162. Dechra Pharmaceuticals Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 163. Dechra Pharmaceuticals Pet Disease Drugs Product Portfolio Table 164. Dechra Pharmaceuticals Recent Development Table 165. Chanelle Pharma Company Information Table 166. Chanelle Pharma Business Overview Table 167. Chanelle Pharma Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 168. Chanelle Pharma Pet Disease Drugs Product Portfolio Table 169. Chanelle Pharma Recent Development Table 170. Ceva Company Information Table 171. Ceva Business Overview Table 172. Ceva Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 173. Ceva Pet Disease Drugs Product Portfolio Table 174. Ceva Recent Development Table 175. Century Pharmaceuticals Company Information Table 176. Century Pharmaceuticals Business Overview Table 177. Century Pharmaceuticals Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 178. Century Pharmaceuticals Pet Disease Drugs Product Portfolio Table 179. Century Pharmaceuticals Recent Development Table 180. Calier Company Information Table 181. Calier Business Overview Table 182. Calier Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 183. Calier Pet Disease Drugs Product Portfolio Table 184. Calier Recent Development Table 185. Boehringer Ingelheim Company Information Table 186. Boehringer Ingelheim Business Overview Table 187. Boehringer Ingelheim Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 188. Boehringer Ingelheim Pet Disease Drugs Product Portfolio Table 189. Boehringer Ingelheim Recent Development Table 190. Bimeda Company Information Table 191. Bimeda Business Overview Table 192. Bimeda Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 193. Bimeda Pet Disease Drugs Product Portfolio Table 194. Bimeda Recent Development Table 195. Avazzia Company Information Table 196. Avazzia Business Overview Table 197. Avazzia Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 198. Avazzia Pet Disease Drugs Product Portfolio Table 199. Avazzia Recent Development Table 200. Assisi Animal Health Company Information Table 201. Assisi Animal Health Business Overview Table 202. Assisi Animal Health Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 203. Assisi Animal Health Pet Disease Drugs Product Portfolio Table 204. Assisi Animal Health Recent Development Table 205. Ashish Life Science Company Information Table 206. Ashish Life Science Business Overview Table 207. Ashish Life Science Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 208. Ashish Life Science Pet Disease Drugs Product Portfolio Table 209. Ashish Life Science Recent Development Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Pet Disease Drugs Distributors List Table 213. Pet Disease Drugs Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Pet Disease Drugs Product Image Figure 2. Global Pet Disease Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Disease Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pet Disease Drugs Sales (2021-2032) & (k units) Figure 5. Global Pet Disease Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Pet Disease Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Analgesics Image Figure 10. Anti-inflammatory Image Figure 11. Parasiticides Image Figure 12. Anti-infectives Image Figure 13. Others Image Figure 14. Global Pet Disease Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Pet Disease Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Pet Disease Drugs Sales Volume Share by Type (2021-2032) Figure 17. Global Pet Disease Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pet Disease Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pet Disease Drugs Sales Value Share by Type (2021-2032) Figure 20. Behavioral Diseases Image Figure 21. Pain Image Figure 22. Dermatologic Diseases Image Figure 23. Orthopedic Diseases Image Figure 24. Infectious Diseases Image Figure 25. Other Image Figure 26. Global Pet Disease Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Pet Disease Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Pet Disease Drugs Sales Volume Share by Application (2021-2032) Figure 29. Global Pet Disease Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Pet Disease Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Pet Disease Drugs Sales Value Share by Application (2021-2032) Figure 32. Global Pet Disease Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 33. Global Pet Disease Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Pet Disease Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Pet Disease Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Pet Disease Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. North America Pet Disease Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Pet Disease Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Pet Disease Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Pet Disease Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Pet Disease Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Pet Disease Drugs Sales Value (2021-2032) & (US$ Million) Figure 43. South America Pet Disease Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Pet Disease Drugs Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Pet Disease Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Pet Disease Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Pet Disease Drugs Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Pet Disease Drugs Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Anti-inflammatory
  • Parasiticides
  • Anti-infectives
  • Others
Applications
  • Behavioral Diseases
  • Pain
  • Dermatologic Diseases
  • Orthopedic Diseases
  • Infectious Diseases
  • Other
Companies covered
  • Zoetis
  • Merck & Co., Inc.
  • Zuche Pharmaceuticals
  • Virbac
  • Vetoquinol S.A.
  • VETINDIA Pharmaceuticals
  • SOUND Technologies
  • SeQuent Scientific
  • Richter Pharma
  • Ourofino Animal Health
  • Norbrook Laboratories
  • Multi Radiance Medical
  • Morvel Laboratories
  • LABINDIA Healthcare
  • K-Laser USA
  • IRM Enterprises
  • Fidelis Animal Health
  • Elanco Animal Health
  • Dechra Pharmaceuticals
  • Chanelle Pharma
  • Ceva
  • Century Pharmaceuticals
  • Calier
  • Boehringer Ingelheim
  • Bimeda
  • Avazzia
  • Assisi Animal Health
  • Ashish Life Science

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Disease Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Pet Disease Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Pet Disease Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pet Disease Drugs Market Dynamics
  1. 2.1 Pet Disease Drugs Industry Trends
  2. 2.2 Pet Disease Drugs Industry Drivers
  3. 2.3 Pet Disease Drugs Industry Opportunities and Challenges
  4. 2.4 Pet Disease Drugs Industry Restraints
3 Pet Disease Drugs Market by Company
  1. 3.1 Global Pet Disease Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Pet Disease Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Pet Disease Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Pet Disease Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Pet Disease Drugs Company Ranking (2024-2026)
  6. 3.6 Global Pet Disease Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Pet Disease Drugs Company Product Type and Application
  8. 3.8 Global Pet Disease Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pet Disease Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pet Disease Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pet Disease Drugs Market by Type
  1. 4.1 Pet Disease Drugs Type Introduction
  2. 4.1.1 Analgesics
  3. 4.1.2 Anti-inflammatory
  4. 4.1.3 Parasiticides
  5. 4.1.4 Anti-infectives
  6. 4.1.5 Others
  7. 4.2 Global Pet Disease Drugs Sales Volume by Type
  8. 4.2.1 Global Pet Disease Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pet Disease Drugs Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Pet Disease Drugs Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Pet Disease Drugs Sales Value by Type
  12. 4.3.1 Global Pet Disease Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Pet Disease Drugs Sales Value by Type (2021-2032)
  14. 4.3.3 Global Pet Disease Drugs Sales Value Share by Type (2021-2032)
5 Pet Disease Drugs Market by Application
  1. 5.1 Pet Disease Drugs Application Introduction
  2. 5.1.1 Behavioral Diseases
  3. 5.1.2 Pain
  4. 5.1.3 Dermatologic Diseases
  5. 5.1.4 Orthopedic Diseases
  6. 5.1.5 Infectious Diseases
  7. 5.1.6 Other
  8. 5.2 Global Pet Disease Drugs Sales Volume by Application
  9. 5.2.1 Global Pet Disease Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Pet Disease Drugs Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Pet Disease Drugs Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Pet Disease Drugs Sales Value by Application
  13. 5.3.1 Global Pet Disease Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Pet Disease Drugs Sales Value by Application (2021-2032)
  15. 5.3.3 Global Pet Disease Drugs Sales Value Share by Application (2021-2032)
6 Pet Disease Drugs Regional Sales and Value Analysis
  1. 6.1 Global Pet Disease Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Disease Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Disease Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Pet Disease Drugs Sales by Region (2027-2032)
  5. 6.3 Global Pet Disease Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pet Disease Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pet Disease Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pet Disease Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Pet Disease Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pet Disease Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Pet Disease Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pet Disease Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Pet Disease Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pet Disease Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pet Disease Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pet Disease Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Pet Disease Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pet Disease Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pet Disease Drugs Sales Value Share by Country, 2025 VS 2032
7 Pet Disease Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Pet Disease Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Disease Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pet Disease Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Pet Disease Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Pet Disease Drugs Sales by Country (2027-2032)
  6. 7.4 Global Pet Disease Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pet Disease Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pet Disease Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pet Disease Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pet Disease Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pet Disease Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Pet Disease Drugs Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Pet Disease Drugs Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 Zuche Pharmaceuticals
  14. 8.3.1 Zuche Pharmaceuticals Company Information
  15. 8.3.2 Zuche Pharmaceuticals Business Overview
  16. 8.3.3 Zuche Pharmaceuticals Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zuche Pharmaceuticals Pet Disease Drugs Product Portfolio
  18. 8.3.5 Zuche Pharmaceuticals Recent Developments
  19. 8.4 Virbac
  20. 8.4.1 Virbac Company Information
  21. 8.4.2 Virbac Business Overview
  22. 8.4.3 Virbac Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Virbac Pet Disease Drugs Product Portfolio
  24. 8.4.5 Virbac Recent Developments
  25. 8.5 Vetoquinol S.A.
  26. 8.5.1 Vetoquinol S.A. Company Information
  27. 8.5.2 Vetoquinol S.A. Business Overview
  28. 8.5.3 Vetoquinol S.A. Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Vetoquinol S.A. Pet Disease Drugs Product Portfolio
  30. 8.5.5 Vetoquinol S.A. Recent Developments
  31. 8.6 VETINDIA Pharmaceuticals
  32. 8.6.1 VETINDIA Pharmaceuticals Company Information
  33. 8.6.2 VETINDIA Pharmaceuticals Business Overview
  34. 8.6.3 VETINDIA Pharmaceuticals Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolio
  36. 8.6.5 VETINDIA Pharmaceuticals Recent Developments
  37. 8.7 SOUND Technologies
  38. 8.7.1 SOUND Technologies Company Information
  39. 8.7.2 SOUND Technologies Business Overview
  40. 8.7.3 SOUND Technologies Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SOUND Technologies Pet Disease Drugs Product Portfolio
  42. 8.7.5 SOUND Technologies Recent Developments
  43. 8.8 SeQuent Scientific
  44. 8.8.1 SeQuent Scientific Company Information
  45. 8.8.2 SeQuent Scientific Business Overview
  46. 8.8.3 SeQuent Scientific Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 SeQuent Scientific Pet Disease Drugs Product Portfolio
  48. 8.8.5 SeQuent Scientific Recent Developments
  49. 8.9 Richter Pharma
  50. 8.9.1 Richter Pharma Company Information
  51. 8.9.2 Richter Pharma Business Overview
  52. 8.9.3 Richter Pharma Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Richter Pharma Pet Disease Drugs Product Portfolio
  54. 8.9.5 Richter Pharma Recent Developments
  55. 8.10 Ourofino Animal Health
  56. 8.10.1 Ourofino Animal Health Company Information
  57. 8.10.2 Ourofino Animal Health Business Overview
  58. 8.10.3 Ourofino Animal Health Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ourofino Animal Health Pet Disease Drugs Product Portfolio
  60. 8.10.5 Ourofino Animal Health Recent Developments
  61. 8.11 Norbrook Laboratories
  62. 8.11.1 Norbrook Laboratories Company Information
  63. 8.11.2 Norbrook Laboratories Business Overview
  64. 8.11.3 Norbrook Laboratories Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Norbrook Laboratories Pet Disease Drugs Product Portfolio
  66. 8.11.5 Norbrook Laboratories Recent Developments
  67. 8.12 Multi Radiance Medical
  68. 8.12.1 Multi Radiance Medical Company Information
  69. 8.12.2 Multi Radiance Medical Business Overview
  70. 8.12.3 Multi Radiance Medical Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Multi Radiance Medical Pet Disease Drugs Product Portfolio
  72. 8.12.5 Multi Radiance Medical Recent Developments
  73. 8.13 Morvel Laboratories
  74. 8.13.1 Morvel Laboratories Company Information
  75. 8.13.2 Morvel Laboratories Business Overview
  76. 8.13.3 Morvel Laboratories Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Morvel Laboratories Pet Disease Drugs Product Portfolio
  78. 8.13.5 Morvel Laboratories Recent Developments
  79. 8.14 LABINDIA Healthcare
  80. 8.14.1 LABINDIA Healthcare Company Information
  81. 8.14.2 LABINDIA Healthcare Business Overview
  82. 8.14.3 LABINDIA Healthcare Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 LABINDIA Healthcare Pet Disease Drugs Product Portfolio
  84. 8.14.5 LABINDIA Healthcare Recent Developments
  85. 8.15 K-Laser USA
  86. 8.15.1 K-Laser USA Company Information
  87. 8.15.2 K-Laser USA Business Overview
  88. 8.15.3 K-Laser USA Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 K-Laser USA Pet Disease Drugs Product Portfolio
  90. 8.15.5 K-Laser USA Recent Developments
  91. 8.16 IRM Enterprises
  92. 8.16.1 IRM Enterprises Company Information
  93. 8.16.2 IRM Enterprises Business Overview
  94. 8.16.3 IRM Enterprises Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 IRM Enterprises Pet Disease Drugs Product Portfolio
  96. 8.16.5 IRM Enterprises Recent Developments
  97. 8.17 Fidelis Animal Health
  98. 8.17.1 Fidelis Animal Health Company Information
  99. 8.17.2 Fidelis Animal Health Business Overview
  100. 8.17.3 Fidelis Animal Health Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Fidelis Animal Health Pet Disease Drugs Product Portfolio
  102. 8.17.5 Fidelis Animal Health Recent Developments
  103. 8.18 Elanco Animal Health
  104. 8.18.1 Elanco Animal Health Company Information
  105. 8.18.2 Elanco Animal Health Business Overview
  106. 8.18.3 Elanco Animal Health Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Elanco Animal Health Pet Disease Drugs Product Portfolio
  108. 8.18.5 Elanco Animal Health Recent Developments
  109. 8.19 Dechra Pharmaceuticals
  110. 8.19.1 Dechra Pharmaceuticals Company Information
  111. 8.19.2 Dechra Pharmaceuticals Business Overview
  112. 8.19.3 Dechra Pharmaceuticals Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Dechra Pharmaceuticals Pet Disease Drugs Product Portfolio
  114. 8.19.5 Dechra Pharmaceuticals Recent Developments
  115. 8.20 Chanelle Pharma
  116. 8.20.1 Chanelle Pharma Company Information
  117. 8.20.2 Chanelle Pharma Business Overview
  118. 8.20.3 Chanelle Pharma Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Chanelle Pharma Pet Disease Drugs Product Portfolio
  120. 8.20.5 Chanelle Pharma Recent Developments
  121. 8.21 Ceva
  122. 8.21.1 Ceva Company Information
  123. 8.21.2 Ceva Business Overview
  124. 8.21.3 Ceva Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Ceva Pet Disease Drugs Product Portfolio
  126. 8.21.5 Ceva Recent Developments
  127. 8.22 Century Pharmaceuticals
  128. 8.22.1 Century Pharmaceuticals Company Information
  129. 8.22.2 Century Pharmaceuticals Business Overview
  130. 8.22.3 Century Pharmaceuticals Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Century Pharmaceuticals Pet Disease Drugs Product Portfolio
  132. 8.22.5 Century Pharmaceuticals Recent Developments
  133. 8.23 Calier
  134. 8.23.1 Calier Company Information
  135. 8.23.2 Calier Business Overview
  136. 8.23.3 Calier Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Calier Pet Disease Drugs Product Portfolio
  138. 8.23.5 Calier Recent Developments
  139. 8.24 Boehringer Ingelheim
  140. 8.24.1 Boehringer Ingelheim Company Information
  141. 8.24.2 Boehringer Ingelheim Business Overview
  142. 8.24.3 Boehringer Ingelheim Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Boehringer Ingelheim Pet Disease Drugs Product Portfolio
  144. 8.24.5 Boehringer Ingelheim Recent Developments
  145. 8.25 Bimeda
  146. 8.25.1 Bimeda Company Information
  147. 8.25.2 Bimeda Business Overview
  148. 8.25.3 Bimeda Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Bimeda Pet Disease Drugs Product Portfolio
  150. 8.25.5 Bimeda Recent Developments
  151. 8.26 Avazzia
  152. 8.26.1 Avazzia Company Information
  153. 8.26.2 Avazzia Business Overview
  154. 8.26.3 Avazzia Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Avazzia Pet Disease Drugs Product Portfolio
  156. 8.26.5 Avazzia Recent Developments
  157. 8.27 Assisi Animal Health
  158. 8.27.1 Assisi Animal Health Company Information
  159. 8.27.2 Assisi Animal Health Business Overview
  160. 8.27.3 Assisi Animal Health Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  161. 8.27.4 Assisi Animal Health Pet Disease Drugs Product Portfolio
  162. 8.27.5 Assisi Animal Health Recent Developments
  163. 8.28 Ashish Life Science
  164. 8.28.1 Ashish Life Science Company Information
  165. 8.28.2 Ashish Life Science Business Overview
  166. 8.28.3 Ashish Life Science Pet Disease Drugs Sales, Value and Gross Margin (2021-2026)
  167. 8.28.4 Ashish Life Science Pet Disease Drugs Product Portfolio
  168. 8.28.5 Ashish Life Science Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Disease Drugs Value Chain Analysis
  2. 9.1.1 Pet Disease Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Disease Drugs Sales Mode & Process
  6. 9.2 Pet Disease Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Disease Drugs Distributors
  9. 9.2.3 Pet Disease Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst